Reality stars hawk allergy drugs

Share this article:
Reality stars hawk allergy drugs
Reality stars hawk allergy drugs
Spring is in the air, and that means, well, sure, robins, daffodils, love and all that, but more importantly, campaigns for allergy drugs featuring endorsements by B-list celebrity sufferers.

This season's famous sneezers include soap star-turned-reality show host Alison Sweeney for McNeil Consumer's Zyrtec Liquid Gels and American Idol judge Kara DioGuardi for Merck's Claritin.

Sweeney, a longtime Days of Our Lives star and host of The Biggest Loser, took part in a Zyrtec event in which she raced six people in nose costumes. Dubbed “Race Against Your Allergies,” the stunt took place in New York City's Madison Square Park and delighted onlookers, including a few MM&M staffers.  

“With new Zyrtec Liquid Gels, people can get relief at liquid speed,” quipped McNeil VP marketing, upper respiratory Rohinish Hooda.

Meanwhile, DioGuardi is serving as the face of Claritin's Living Clear campaign, a user-generated content effort that invites users to submit a video to showing what Claritin's non-drowsy formula has enabled them to do. Finalists will be announced May 6, and votes from visitors will decide the ultimate winner, who will pocket a $10,000 prize and win a chance to star in a Claritin online ad, while five finalists take home $1,000 and a one-year supply of Claritin products.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...